| The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix. | |
| | |
MedLine Citation:
|
PMID: 3957119 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The prognostic value of estrogen receptors (ER) and progesterone receptors (PR) was studied in 246 women with primary carcinoma of the uterine cervix. In addition to the receptor status information on tumor stage, histological type, age at operation, and menopausal status was recorded and analyzed. If the patient died the cause of death was ascertained. The median survival time for the 97 patients who died was 15 months and the survivors were followed for an average of 34 months. The survival curve was compared with an age, sex, and year of death matched West-Australian population. The survival curves for patients with ER+ or ER- and PR+ or PR- tumors were virtually indistinguishable. Overall survival in patients with cervical carcinoma is not influenced by the receptor status or the receptor concentration of the carcinoma. |
| | |
Authors:
|
J D Martin; R Hähnel; A J McCartney; N De Klerk |
Related Documents
:
|
18176089 - Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lun... 4016669 - Chemohormonal therapy for advanced breast cancer with tamoxifen, adriamycin, and cyclop... 17634479 - Quantitative measurement of epidermal growth factor receptor is a negative predictive f... 19477549 - Egfr mutations are associated with prognosis but not with the response to front-line ch... 18381949 - The potential predictive value of cyclooxygenase-2 expression and increased risk of gas... 3806159 - Survival from first recurrence: relative importance of prognostic factors in 1,015 brea... 7438959 - Hemangioendothelial sarcoma of the liver associated with long-term estrogen therapy in ... 22788989 - A clinical phase i/ii trial to investigate preoperative dose-escalated intensity-modula... 7928489 - National cancer institute (phase ii) study of high-grade glioma treated with accelerate... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Gynecologic oncology Volume: 23 ISSN: 0090-8258 ISO Abbreviation: Gynecol. Oncol. Publication Date: 1986 Mar |
Date Detail:
|
Created Date: 1986-04-29 Completed Date: 1986-04-29 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0365304 Medline TA: Gynecol Oncol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 329-35 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carcinoma
/
analysis,
mortality* Female Follow-Up Studies Humans Middle Aged Neoplasm Staging Receptors, Estrogen / analysis* Receptors, Progesterone / analysis* Uterine Cervical Neoplasms / analysis, mortality* |
| Chemical | |
Reg. No./Substance:
|
0/Receptors, Estrogen; 0/Receptors, Progesterone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: cis-Platinum as adjunctive to surgery in early stage ovarian carcinoma: effects on lymphoid cell sub...
Next Document: Strategies in late stage cervix carcinoma.